ALTO - Alto Ingredients, Inc.
NASDAQ
->
Basic Materials
->
Specialty Chemicals
Sacramento,
United States
Type: Equity
ALTO price evolution
ALTO
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $58.73 | $66.1 | $63.37 | $66.54 |
| Inventory | $52.61 | $57.1 | $71.11 | $67.15 |
| Total current assets | $168.77 | $168.2 | $179.53 | $171.6 |
| Long term investments | ||||
| Property, plant & equipment | $271.35 | $272.3 | $271.13 | $267.22 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $454.24 | $461.1 | $471.41 | $459.9 |
| Current liabilities | ||||
| Accounts payable | $20.75 | $24 | $25.93 | $24.41 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $65.29 | $58.4 | $58.69 | $53.85 |
| Long term debt | $82.1 | $75.9 | $82.08 | $83.74 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $174.68 | $163.1 | $170.62 | $166.23 |
| Shareholders' equity | ||||
| Retained earnings | -$763.91 | -$744.6 | -$740.84 | -$748.12 |
| Other shareholder equity | $2.48 | $1.8 | $1.82 | $1.82 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $47.67 | |||
| Short term investments | ||||
| Net receivables | $58.73 | $68.66 | $86.89 | $43.49 |
| Inventory | $52.61 | $66.63 | $54.37 | $41.77 |
| Total current assets | $168.77 | $199.12 | $229.53 | $214.05 |
| Long term investments | ||||
| Property, plant & equipment | $271.35 | $258.01 | $235.96 | $229.49 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $262.77 | |||
| Total investments | ||||
| Total assets | $454.24 | $478.32 | $484.95 | $476.82 |
| Current liabilities | ||||
| Accounts payable | $20.75 | $28.11 | $23.25 | $13.05 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $65.29 | $78.02 | $69.6 | $86.93 |
| Long term debt | $82.1 | $68.36 | $50.36 | $71.81 |
| Total noncurrent liabilities | $93.66 | |||
| Total debt | ||||
| Total liabilities | $174.68 | $170.23 | $139.74 | $180.58 |
| Shareholders' equity | ||||
| Retained earnings | -$763.91 | -$734.64 | -$691.78 | -$736.6 |
| Other shareholder equity | $2.48 | $1.82 | -$0.28 | -$3.88 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $308.12 | |||
| Cost of revenue | ||||
| Gross Profit | $4.77 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $7.62 | |||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | -$0.2 | |||
| Net income | ||||
| Net income | -$2.6 | |||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | 31 Jan 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $897.02 | $1424.88 | $1515.37 | |
| Cost of revenue | ||||
| Gross Profit | $52.86 | -$9.94 | -$15.16 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $43.17 | $65.56 | $36.91 | |
| Operating income | $9.85 | -$74.68 | -$51.54 | |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.02 | -$0.02 | -$0.56 | |
| Interest expense | $17.94 | $20.21 | $17.13 | |
| Net income | ||||
| Net income | -$15.12 | -$88.95 | -$60.27 | |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$25.15 | -$24.42 | -$16.99 | $27.12 |
| Financing activities | ||||
| Dividends paid | -$0.95 | -$0.63 | -$0.31 | -$2.85 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$6.4 | $16.33 | $3.78 | -$40 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$29.71 | $12.61 | -$2.15 | $13.94 |
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | 31 Jan 2019 |
|---|---|---|---|---|
| Net income | -$17.28 | -$101.28 | -$67.94 | |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $71.78 | -$23.36 | $1.57 | |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $27.12 | $23.32 | -$3.28 | -$15.15 |
| Financing activities | ||||
| Dividends paid | -$2.85 | -$0.95 | -$1.26 | |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$40 | -$66.42 | $19.01 | -$9.27 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $13.94 | $28.67 | -$7.63 | -$22.86 |
News
Fundamentals
| Market cap | $146.11M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 75.70M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.59 |
| Quick ratio | 1.78 |